专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明授权

US07420961B2 Distributed modem 有权
标题翻译：分布式调制解调器
公开(公告)号：US07420961B2
公开(公告)日：2008-09-02
申请号：US10311189
申请日：2001-06-11
申请人： Abraham Fisher , Oren Somekh
发明人： Abraham Fisher , Oren Somekh
IPC分类号： H04L12/64 , H04M11/06
CPC分类号： H04L12/5692 , H04L12/2859 , H04L12/2898 , H04L12/4604 , H04L12/4633 , H04L29/06 , H04L69/16 , H04L69/164 , H04L69/165 , H04L69/169 , H04L69/24 , H04N1/001 , H04N1/00209 , H04N2201/0024 , H04N2201/0025 , H04N2201/0039 , H04N2201/0086 , H04N2201/0093
摘要： A method of transmitting data bits over a modem connection. The method includes receiving a first stream of data bits, by a first modem, performing a first set of one or more communication tasks on the first stream of bits, by the first modem, so as to generate a second stream of bits, modulating the second stream of bits, by the first modem, so as to form a modulated signal, transmitting the modulated signal from the first modem to a second modem, demodulating the modulated signal by the second modem, so as to form a third stream of bits, performing on the third stream of bits, a second set of zero or more communication tasks, including a different number of tasks than the first set of tasks, so as to form a fourth stream of bits, and transmitting the fourth stream of bits to a communication unit over a packet based network.
摘要翻译：一种通过调制解调器连接传输数据位的方法。该方法包括：由第一调制解调器接收第一数据比特流，由第一调制解调器在第一比特流上执行一个或多个通信任务的第一组，以产生第二比特流，调制通过第一调制解调器，以形成调制信号，将调制信号从第一调制解调器发送到第二调制解调器，由第二调制解调器解调调制信号，以形成第三比特流，在所述第三比特流上执行第二组零个或多个通信任务，包括不同于第一组任务的不同数量的任务，以便形成第四比特流，并将所述第四比特流传送到通信单元通过基于分组的网络。

32. 发明授权

US07406072B1 Modem relay over packet based network 有权
标题翻译：调制解调器通过基于分组的网络进行中继
公开(公告)号：US07406072B1
公开(公告)日：2008-07-29
申请号：US10276765
申请日：2000-08-13
申请人： Oren Somekh , Abraham Fisher , Yona Sivan
发明人： Oren Somekh , Abraham Fisher , Yona Sivan
IPC分类号： H04L12/66
CPC分类号： H04L12/5692 , H04L12/4604 , H04L12/4633 , H04L29/06 , H04L69/16 , H04L69/164 , H04L69/165 , H04L69/169 , H04M11/066 , H04N1/001 , H04N1/00209 , H04N1/00214 , H04N1/0022 , H04N1/327 , H04N1/32789 , H04N2201/0024 , H04N2201/0025 , H04N2201/0039 , H04N2201/0086 , H04N2201/0093
摘要： A method of transmitting signals between a source modem and a destination modem. The method includes transmitting the signals from the source modem, over a first switched network path, to a first interface, encapsulating the at least some of the signals received by the first interface into packets, transmitting the packets from the first interface over a packet-based network to a second interface, removing the encapsulation of the signals at the second interface; and transmitting the data signals from the second interface over a second switched network path to the destination modem.
摘要翻译：一种在源调制解调器和目的调制解调器之间传输信号的方法。该方法包括：将来自源调制解调器的信号通过第一交换网络路径发送到第一接口，将由第一接口接收的至少一些信号封装成分组，通过分组传送来自第一接口的分组，基于网络到第二接口，去除在第二接口处的信号的封装; 以及通过第二交换网络路径将数据信号从第二接口发送到目的地调制解调器。

33. 发明申请

US20070201435A1 Transmission Of Video Over Ip 审中-公开
标题翻译：视频传输Ip
公开(公告)号：US20070201435A1
公开(公告)日：2007-08-30
申请号：US11569184
申请日：2005-04-21
申请人： Abraham Fisher
发明人： Abraham Fisher
IPC分类号： H04L12/66 , H04L12/56
CPC分类号： H04L29/06027 , H04L65/1006 , H04L65/1009 , H04L65/103 , H04L65/104 , H04L65/403 , H04L65/4038 , H04L65/605 , H04N21/6131 , H04N21/64322 , H04N21/64707 , H04W88/16
摘要： A method of handling video signals by a gateway. The method includes determining, by the gateway, that a circuit switched channel carries video signals, receiving, by the gateway, a signal stream from the circuit switched channel determined to carry video signals, placing the signals of the received signal stream in packets of a single packet connection and transmitting the packets of the single packet connection, by the gateway, on a packet based network.
摘要翻译：一种由网关处理视频信号的方法。该方法包括由网关确定电路交换信道承载视频信号，由网关接收来自确定携带视频信号的电路交换信道的信号流，将接收信号流的信号置于单个分组连接，并通过网关在基于分组的网络上传送单个分组连接的分组。

34. 发明授权

US07068764B1 V.90 over all-digital connections 失效
标题翻译： V.90全数字连接
公开(公告)号：US07068764B1
公开(公告)日：2006-06-27
申请号：US10220179
申请日：2000-03-29
申请人： Abraham Fisher , Oren Somekh
发明人： Abraham Fisher , Oren Somekh
IPC分类号： H04M11/00
CPC分类号： H04M11/066 , H04L5/1438 , H04L25/4927 , H04M11/06
摘要： A method of forming a V.90 connection on an all digital connection. The method includes transmitting a request to connect from a digitally connected client modem (28) to a digitally connected server modem (24) and transmitting, by the client modem (28) to the server modem, a message requesting to form a V.90 connection, identifying the digitally connected client modem (28) as an analog connected modem.
摘要翻译：一种在所有数字连接上形成V.90连接的方法。该方法包括发送从数字连接的客户端调制解调器（28）连接到数字连接的服务器调制解调器（24）并由客户端调制解调器（28）向服务器调制解调器发送请求形成V.90的消息的请求连接，将数字连接的客户端调制解调器（28）识别为模拟连接的调制解调器。

35. 发明申请

US20060052406A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor 失效
标题翻译：用于治疗中枢和周围神经系统疾病的方法和组合物及其有用的新化合物
公开(公告)号：US20060052406A1
公开(公告)日：2006-03-09
申请号：US10512673
申请日：2003-05-01
申请人： Abraham Fisher , Nira Bar-Ner , Yishai Karton
发明人： Abraham Fisher , Nira Bar-Ner , Yishai Karton
IPC分类号： A61K31/522 , A61K31/498 , A61K31/497 , A61K31/4745 , C07D473/02 , C07D471/10
CPC分类号： C07D513/10 , C07B2200/05 , C07D471/10 , C07D491/10
摘要： There are provided methods for the treatment of diseases involving dysfunction of the peripheral and central nervous system comprising administering one or more spiro compounds. Also provided are pharmaceutical compositions useful in such methods, compounds for use in the preparation of such pharmaceutical compositions, processes for preparing compounds useful in the practice of such methods, and some novel such compounds per se.
摘要翻译：提供了治疗涉及周围和中枢神经系统功能障碍的疾病的方法，包括给予一种或多种螺环化合物。还提供了可用于这些方法的药物组合物，用于制备这种药物组合物的化合物，用于制备用于实施这些方法的化合物的方法，以及一些新的这类化合物本身。

36. 发明授权

US5852029A Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity 失效
标题翻译：作用于具有毒蕈碱激动剂活性的胆碱能系统的佐氮螺环化合物
公开(公告)号：US5852029A
公开(公告)日：1998-12-22
申请号：US627222
申请日：1996-01-18
申请人： Abraham Fisher , Yishal Karton , Daniele Marciano , Dov Barak , Haim Meshulam
发明人： Abraham Fisher , Yishal Karton , Daniele Marciano , Dov Barak , Haim Meshulam
IPC分类号： C07D471/10 , C07D471/20 , C07D491/10 , C07D497/10 , C07D498/10 , C07D498/20 , C07D513/10 , A61K31/445 , A61K31/46 , C07D491/20
CPC分类号： C07D471/10 , C07D491/10 , C07D497/10 , C07D513/10
摘要： Compounds useful for treating diseases of the central or peripheral nervous system in mammals have formulae I-XII ##STR1## wherein ring A or A' together with the spiro-carbon atom constitutes a bridged or unbridged ring containing one or two ring nitrogen atoms; and the other symbols have specified values, subject to certain conditions.
摘要翻译：可用于治疗哺乳动物中枢神经系统或周围神经系统疾病的化合物具有式I-XII I II III IV V VI VII 其中环A或A'与螺 - 碳原子一起构成含有一个或两个环氮原子的桥连或非桥连环; 并且其他符号具有指定的值，在某些条件下。

37. 发明授权

US5407938A Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines) 失效
标题翻译：某些1-甲基 - 哌啶-4-螺-4' - （1'-3'-恶唑啉）和相应的 - （1'，3'噻唑啉）
公开(公告)号：US5407938A
公开(公告)日：1995-04-18
申请号：US137690
申请日：1993-10-14
申请人： Abraham Fisher , Yoffi Segall , Ezra Shirin , Yishai Karton , Haim Meshulam
发明人： Abraham Fisher , Yoffi Segall , Ezra Shirin , Yishai Karton , Haim Meshulam
IPC分类号： C07D471/10 , C07D471/20 , C07D491/10 , C07D497/10 , C07D498/10 , C07D498/20 , C07D513/10 , A61K31/44 , C07D491/20 , C07D495/20 , C07D497/20
CPC分类号： C07D471/10 , C07D491/10 , C07D497/10 , C07D513/10
摘要： The invention relates to compounds (I) for treating diseases of the central and peripheral nervous system, including enantiomers, racemates and acid addition and quaternary salts, ##STR1## wherein Q is selected from two H atoms, (CH.sub.2).sub.m and C(CH.sub.3).sub.2 where m is 1, 2 or 3 and n and p are; each independently 0, 1, 2 or 3, provided that n+p=1-3, and R.sup.0 is H, methyl or OH; the moiety ##STR2## R is selected from H, NH.sub.2, NH-C.sub.1-6 -alkyl, N(C.sub.1-6 -alkyl).sub.2, C.sub.1-6 -alkyl, C.sub.2-6 -alkenyl, C.sub.2-6 -alkynyl, C.sub.3-7 - cycloalkyl, C.sub.1-6 -alkyl substituted by 1-6 halogen atoms, hydroxy- C.sub.1-6 -alkyl, C.sub.1-6 -alkoxy, C.sub.1-6 -alkylthio, C.sub.1-6 -alkoxy-C.sub.1-6 -alkyl, carboxy-C.sub.1-6 -alkyl, (C.sub.1-6 -alkoxy)carbonyl-C.sub.1-6 -alkyl, amino-C.sub.1-6 -alkyl, mono-(C.sub.1-6 -alkyl)amino-C.sub.1-6 -alkyl, di-(C.sub.1-6 -alkyl)amino-C.sub.1-6 -alkyl, 2-oxo-pyrrolidin-1-yl-methyl, aryl, diarylmethylol, and C.sub.1-6 -alkyl substituted by one or two aryl groups; R' is independently selected from the group from which R is selected and C.sub.1-6 -alkanoyl and arylcarbonyl; and aryl denotes unsubstituted phenyl or phenyl substituted by 1-3 substituents selected from halogen, C.sub.1-6 -alkyl, C.sub.1-6 -alkoxy and CF.sub.3, subject to certain provisos.
摘要翻译：本发明涉及用于治疗中枢和周围神经系统疾病的化合物（I），包括对映体，外消旋体和酸加成和季盐。其中Q选自两个H原子，（CH 2）m和 C（CH 3）2，其中m为1,2或3，n和p为每个独立地为0,1,2或3，条件是n + p = 1-3，R 0为H，甲基或OH; R 1选自H，NH 2，NH-C 1-6 - 烷基，N（C 1-6 - 烷基）2，C 1-6 - 烷基，C 2-6 - 烯基，C 2-6 - 炔基，C 3 -7-环烷基，被1-6个卤素原子取代的C 1-6 - 烷基，羟基-C 1-6 - 烷基，C 1-6 - 烷氧基，C 1-6 - 烷硫基，C 1-6 - 烷氧基-C 1-6 - 烷基，羧基-C 1-6 - 烷基，（C 1-6 - 烷氧基）羰基-C 1-6 - 烷基，氨基-C 1-6 - 烷基，单 - （C 1-6 - 烷基）氨基-C 1-6 - 烷基，（C 1-6 - 烷基）氨基-C 1-6 - 烷基，2-氧代 - 吡咯烷-1-基 - 甲基，芳基，二芳基羟甲基和被一个或两个芳基取代的C 1-6 - 烷基; R'独立地选自选自R的基团和C 1-6 - 烷酰基和芳基羰基; 并且芳基表示未取代的苯基或被1-3个选自卤素，C 1-6 - 烷基，C 1-6 - 烷氧基和CF 3的取代基取代的苯基，具有一定条件。

38. 发明授权

US4876260A Oxathiolanes 失效
标题翻译：硫辛酸
公开(公告)号：US4876260A
公开(公告)日：1989-10-24
申请号：US189210
申请日：1988-05-02
申请人： Abraham Fisher , Ishai Karton
发明人： Abraham Fisher , Ishai Karton
IPC分类号： A61K31/435 , A61K38/04 , A61P25/00 , A61P25/02 , A61P25/28 , C07D497/20
CPC分类号： C07D497/20
摘要： The present invention accordingly provides in one aspect, novel spiro-oxathiolane/quinuclidine compounds corresponding with the schematic structural formula (I) ##STR1## and geometrical isomers, enantiomers, diastereoisomers, racemates and acid addition salts thereof, wherein one of Y and Z is 0 and the other is S(.dbd.O).sub.n ; n is 0, 1 or 2; R' and R" are each selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, hydroxyalkyl, aminoalkyl, C.sub.3-7 cycloalkyl, aryl, diarylmethylol, and alkyl substituted by at least one aryl group, provided that at least R' and R" is other than hydrogen; and each X is hydrogen, or when Y is 0 and Z is S(.dbd.O).sub.n simultaneously, then each X may also be selected from the group consisting of deuterium and tritium, and provided further that when each X is hydrogen, Y is 0 and Z is S simultaneously, then at least one of R' and R" is selected from the group consisting of alkenyl, alkynyl, cyclopropyl, cyclobutyl, cycloheptyl, hydroxyalkyl and aminoalkyl.

39. 发明授权

US4309544A Preparation of 6-oxa-1-azatricyclo(6.2.2.0.sup.2,7)dodecane-5-ones 失效
标题翻译： 6-氧杂-1-氮杂三环（6.2.2.02,7）十二烷-5-酮的制备
公开(公告)号：US4309544A
公开(公告)日：1982-01-05
申请号：US58968
申请日：1979-07-20
申请人： Sasson Cohen , Abraham Fisher
发明人： Sasson Cohen , Abraham Fisher
IPC分类号： C07D453/02 , C07D487/02
CPC分类号： C07D453/02
摘要： The invention relates to the production of compounds of the general formula: ##STR1## wherein X is selected from the group consisting of oxygen, CH.sub.2 and CH radicals, and when X designates oxygen, R designates alkyl, isoalkyl, aralkyl, and substituted aralkyl groups and when X designates CH.sub.2 then R designates alkyl, phenyl or substituted phenyl group, and A-B is a single bond, and when X designates CH.sub.2, R designates alkyl, phenyl or substituted phenyl groups and A-B is a double bond; and physiologically acceptable salts of these, and pharmaceutical composition containing the same as active ingredient.
摘要翻译：本发明涉及以下通式的化合物的制备：其中X选自氧，CH 2和CH自由基，当X表示氧时，R表示烷基，异烷基，芳烷基和取代的芳烷基当X表示CH2时，R表示烷基，苯基或取代的苯基，AB表示单键，当X表示CH2时，R表示烷基，苯基或取代的苯基，AB表示双键; 和这些的生理上可接受的盐，以及含有与活性成分相同的药物组合物。

40. 发明授权

US4183938A 1,8-Ethano-5-oxo-octa- and -decahydroquinolines and mydriatic compositions thereof 失效
标题翻译： 1,8-乙酸-5-氧代 - 八 - 和 - 十氢喹啉和散瞳组合物
公开(公告)号：US4183938A
公开(公告)日：1980-01-15
申请号：US852402
申请日：1977-11-17
申请人： Sasson Cohen , Abraham Fisher
发明人： Sasson Cohen , Abraham Fisher
IPC分类号： C07D453/02 , A61K31/47 , C07D215/20
CPC分类号： C07D453/02
摘要： Compounds of the general formula: ##STR1## wherein X is selected from the group consisting of oxygen, CH.sub.2 and CH radicals, and when X designates oxygen, R designates alkyl, isoalkyl, aralkyl, and substituted aralkyl groups and when X designates CH.sub.2 then R designates alkyl, phenyl or substituted phenyl group, and A-B is a single bond, and when X designates CH.sub.2 R designates alkyl, phenyl or substituted phenyl groups and A-B is a double bond; and physiologically acceptable salts of these, and mydriatic pharmaceutical compositions containing the same as active ingredient.
摘要翻译：通式为：其中X选自氧，CH 2和CH自由基的化合物，当X表示氧时，R表示烷基，异烷基，芳烷基和取代的芳烷基，当X表示CH2时，则R 表示烷基，苯基或取代的苯基，AB是单键，当X表示CH2 + L时，R表示烷基，苯基或取代的苯基，AB表示双键; 和这些的生理上可接受的盐，以及含有与活性成分相同的散瞳药物组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式